SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility as market participants weigh geopolitical instability in the Middle East against shifting inflationary expectations. Traders are actively debating whether the ongoing energy sector tensions and rhetoric surrounding potential infrastructure impacts will lead to a broader market correction or serve as a buying opportunity for dip-buyers.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood (HOOD) is trending as investors debate the stock's long-term potential following a significant correction and its heavy correlation with crypto market volatility. While some community members see the current price as a value opportunity supported by new product rollouts like social trading, others are concerned by regulatory headlines and the stock's persistent weakness compared to broader market indices.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas is experiencing intense volatility and community debate as traders weigh the impact of Middle East geopolitical tensions against bearish seasonal trends and concerns over market manipulation. Investors are actively discussing the decoupling of U.S. natural gas from international price surges, with many debating whether the current price action reflects genuine supply disruptions or represents a temporary reaction to rhetoric regarding the Strait of Hormuz.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile US is capturing market attention as investors weigh its competitive positioning in 5G and satellite integration against broader sector-wide pricing pressures and technical consolidation. While some community members remain focused on long-term growth potential and recent institutional accumulation, others are debating the impact of increased industry competition on its forward performance.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as market participants weigh conflicting signals regarding the escalation of the conflict with Iran against potential diplomatic de-escalation efforts. Community sentiment is deeply divided, with traders closely monitoring the Strait of Hormuz, energy prices, and geopolitical headlines for cues on whether to brace for a broader market correction or position for a recovery.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as investors weigh volatile geopolitical risks in the Middle East against bearish seasonal fundamentals like rising production and the approaching shoulder season. The community is actively debating whether ongoing tensions and potential maritime disruptions will provide a lasting floor for prices or if the expected inventory builds will ultimately drive a sharp downward reversal.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing a sharp, volatile sell-off, with investors debating whether this price action represents a temporary liquidity-driven liquidation or a fundamental breakdown of gold's safe-haven narrative. The community is actively discussing the impact of hotter-than-expected producer inflation data, a surging US dollar, and rising yields, while others treat the dip as a strategic opportunity to accumulate physical metal amidst ongoing geopolitical uncertainty.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing intense volatility as investors debate whether the recent sharp price decline is a structural liquidation or a strategic buying opportunity amid rising geopolitical tensions and inflationary concerns. The community remains deeply divided, with many traders actively discussing potential COMEX supply constraints and institutional manipulation, while others warn of further downside risks as the asset struggles to maintain its historical safe-haven status.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

LABU is currently trending as biotech investors capitalize on aggressive market rotation and increased speculative interest fueled by anticipation of further rate cuts and sector-specific buyout activity. Market participants are actively debating whether this rapid momentum represents a sustainable breakout or an overextended rally, leading to high-volume trading and significant volatility in leveraged biotech instruments.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

Biotech remains a resilient outlier as investors rotate capital into the sector, leaving holders of this leveraged inverse ETF frustrated by persistent decoupling from broader market downturns. The community is actively debating the sustainability of this rotation and weighing entry points for a potential reversal, with many closely watching upcoming macroeconomic catalysts and sector-specific news to gauge if a long-overdue correction is finally approaching.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hudson Bay Capital Management LP Purchases Shares of 107,678 Nektar Therapeutics $NKTR

Hudson Bay Capital Management LP acquired a new position in Nektar Therapeutics (NASDAQ:NKTR - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 107,678 shares of the biopharmaceutical company's stock, valued at approximately...

Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Nektar Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit PR Newswire NEW YORK, March 21, 2026 NEW YORK, March 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law...

Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise...

Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting

Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting Data from Phase 2b Studies for Rezpegaldesleukin...

Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR

Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to...

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with...

Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR

Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar...

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Failing Clinical Enrollment Standards: SueWallSt

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Failing Clinical Enrollment Standards: SueWallSt NKTR...

HC Wainwright Issues Positive Estimate for NKTR Earnings

Nektar Therapeutics (NASDAQ:NKTR - Free Report) - Stock analysts at HC Wainwright lifted their Q1 2026 earnings per share estimates for Nektar Therapeutics in a research report issued on Tuesday, March 17th. HC Wainwright analyst A. He now anticipates that the biopharmaceutical company will post ear...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Current Price	$72.22
Prev Close	$74.84
Open	$74.90
Dividend Yield	0.00%
50-Day Moving Average	$56.05
Beta	1.85
Avg. Volume	1.76M
PE Ratio	-7.06

52-Week High	$77.00
52-Week Low	$6.48
Market Capitalization	$2.07B
EPS (Annual)	-$9.73
Price to Book	16.38
Revenue Per Employee	$876,698.41

NKTR
Nektar Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NKTR News

NKTRNektar Therapeutics